BIOCANCELL THERAPEUTICS INC. Increase (Decrease) in Accrued Liabilities
BIOCANCELL THERAPEUTICS INC. reported Increase (Decrease) in Accrued Liabilities of -$20.00 thousand for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2012-05-10
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2012-03-31 was -$20.00K, a 119.80% decline year-over-year.
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2011-12-31 was $203.00K, a 87.96% increase year-over-year.
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2011-09-30 was -$60.00K.
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for the quarter ending 2011-06-30 was $311.00K.
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for fiscal 2011 was $555.00K.
- BIOCANCELL THERAPEUTICS INC. increase (decrease) in accrued liabilities for fiscal 2010 was -$2.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 81 month | Increase (Decrease) in Accrued Liabilities 84 month | Increase (Decrease) in Accrued Liabilities 87 month | Increase (Decrease) in Accrued Liabilities 90 month |
|---|---|---|---|---|---|---|---|---|
| 2012-03-31 | -$20.00K 10-Q · filed 2012-05-10 | $183.00K derived: sum of 2 quarters · filed 2012-05-10 | $123.00K derived: sum of 3 quarters · filed 2012-05-10 | $434.00K derived: sum of 4 quarters · filed 2012-05-10 | $786.00K 10-Q · filed 2012-05-10 | |||
| 2011-12-31 | $203.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $143.00K derived: sum of 2 quarters · filed 2012-03-30 | $454.00K derived: sum of 3 quarters · filed 2012-03-30 | $555.00K 10-K · filed 2012-03-30 | $806.00K 10-K · filed 2012-03-30 | |||
| 2011-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | $251.00K derived: sum of 2 quarters · filed 2011-11-07 | $352.00K 10-Q · filed 2011-11-07 | $460.00K derived: sum of 4 quarters · filed 2012-05-10 | $603.00K 10-Q · filed 2011-11-07 | |||
| 2011-06-30 | $311.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2011-08-30 | $412.00K 10-Q/A · filed 2011-08-30 | $520.00K derived: sum of 3 quarters · filed 2012-05-10 | $500.00K derived: sum of 4 quarters · filed 2012-05-10 | $663.00K 10-Q/A · filed 2011-08-30 | |||
| 2011-03-31 | $101.00K 10-Q · filed 2012-05-10 | $209.00K derived: sum of 2 quarters · filed 2012-05-10 | $189.00K derived: sum of 3 quarters · filed 2012-05-10 | |||||
| 2010-12-31 | $108.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $88.00K derived: sum of 2 quarters · filed 2012-03-30 | -$2.00K 10-K · filed 2012-03-30 | |||||
| 2010-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-07 | -$110.00K 10-Q · filed 2011-11-07 | ||||||
| 2010-06-30 | -$90.00K 10-Q/A · filed 2011-08-30 |